Deal Watch: Sanofi To Tap Owkin’s AI, Machine Learning In Oncology
Executive Summary
French pharma makes $180m equity investment in Owkin under collaboration targeting four cancer types. Pyramid gets global license to MPS1 precision cancer candidate from Voronoi.
You may also be interested in...
Finance Watch: Dementia Discovery Fund’s Behr Sees Early Investments Reviving Neuroscience Interest
Private Company Edition: Scrip spoke with DDF US partner Jonathan Behr about the convergence of emerging science, venture capital investment and rising big pharma interest in neurodegeneration. Also, in recent VC financings HotSpot raised $100m, while Curie and Ablaze debuted with $75m each.
Roche Exit Strengthens Pfizer And Merck & Co In Covid Pill Market
Roche has bowed out of the race to develop an oral COVID-19 therapy, leaving a lucrative but likely short-lived market for its rivals.
Carlyle Builds Diverse Generic Platform With India’s Viyash Life Sciences
Viyash Life Sciences said it intended to seek further investment opportunities to build scale after establishing an integrated generic pharmaceutical platform in India in partnership with the private equity giant Carlyle.